The shares of this firm jumped by 6 % after the corporate introduced that it had acquired a piece order from Gujarat BESS Personal Ltd. On this article, we are going to take a look at the main points of the work order.
With a market capitalization of Rs 1,272 crores, the shares of Advait Vitality Transitions Ltd are at the moment buying and selling at Rs 1,178 per share, down by 48 % from its 52-week excessive of Rs 2,260 per share. During the last 5 years, the inventory has delivered a multibagger return of 4,492.87 %. As of March 2025, Ashish Kacholia holds a 2.67% stake within the firm.
Advait Vitality Transitions Ltd has acquired a piece order from Gujarat BESS Personal Restricted value Rs 7.43 crores. The scope of the work consists of the Provide, Erection, Testing, and Commissioning for the 180 MW / 360 MWh BESS Undertaking (AC Facet) at Gujarat BESS Personal Restricted, Sanand. The mechanical work is deliberate to be accomplished by 30 November 2025, with ultimate charging set for completion by 23 December 2025.
The corporate reported a income progress of 35.38 % to Rs 98.45 crores in Q3 FY25 from Rs 72.71 crores in Q3 FY24. It reported a web revenue progress of 27.28 % to Rs 9.79 crores in Q3 FY25 from Rs 7.69 crores in Q3 FY24. The corporate has an ROE and ROCE of 36.6 % and 37.2 %, respectively, and is at the moment buying and selling at a P/E of 48.24x towards its trade common of 20.38x.
In regards to the firm
Advait Vitality Transitions Restricted presents merchandise and options for the telecom infrastructure, energy transmission, and substation industries in India and overseas. It manufactures and distributes OPGW cables, insulators, aluminum-clad metal wires, and stringing instruments and equipment of various sorts.
The corporate additionally offers in earthing options and has inexperienced vitality initiatives reminiscent of hydrogen electrolysers, photo voltaic EPC initiatives, battery storage methods, and carbon offset consulting.
Written by Satyajeet Mukherjee
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not answerable for any losses triggered because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
